Annual D&A
$59.79 M
+$138.00 K+0.23%
31 December 2023
Summary:
ANI Pharmaceuticals annual depreciation & amortization is currently $59.79 million, with the most recent change of +$138.00 thousand (+0.23%) on 31 December 2023. During the last 3 years, it has risen by +$15.15 million (+33.95%). ANIP annual D&A is now at all-time high.ANIP Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$15.75 M
+$1.05 M+7.15%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly depreciation & amortization is currently $15.75 million, with the most recent change of +$1.05 million (+7.15%) on 30 September 2024. Over the past year, it has increased by +$541.00 thousand (+3.56%). ANIP quarterly D&A is now -2.20% below its all-time high of $16.10 million, reached on 31 March 2019.ANIP Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$60.33 M
+$541.00 K+0.90%
30 September 2024
Summary:
ANI Pharmaceuticals TTM depreciation & amortization is currently $60.33 million, with the most recent change of +$541.00 thousand (+0.90%) on 30 September 2024. Over the past year, it has increased by +$156.00 thousand (+0.26%). ANIP TTM D&A is now at all-time high.ANIP TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +0.2% | +3.6% | +0.3% |
| 3 y3 years | +34.0% | +38.8% | +35.7% |
| 5 y5 years | +77.2% | +66.2% | +37.9% |
ANIP Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +34.0% | at high | +38.8% | at high | +35.7% |
| 5 y | 5 years | at high | +77.2% | at high | +66.2% | at high | +52.0% |
| alltime | all time | at high | >+9999.0% | -2.2% | >+9999.0% | at high | >+9999.0% |
ANI Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $15.75 M(+7.2%) | $60.33 M(+0.9%) |
| June 2024 | - | $14.70 M(+0.1%) | $59.78 M(+0.0%) |
| Mar 2024 | - | $14.69 M(-3.3%) | $59.78 M(-0.0%) |
| Dec 2023 | $59.79 M(+0.2%) | $15.19 M(-0.1%) | $59.79 M(-0.6%) |
| Sept 2023 | - | $15.21 M(+3.5%) | $60.17 M(-0.2%) |
| June 2023 | - | $14.69 M(-0.1%) | $60.31 M(+0.9%) |
| Mar 2023 | - | $14.70 M(-5.6%) | $59.80 M(+0.2%) |
| Dec 2022 | $59.65 M(+26.2%) | $15.57 M(+1.4%) | $59.65 M(+3.3%) |
| Sept 2022 | - | $15.35 M(+8.3%) | $57.77 M(+7.4%) |
| June 2022 | - | $14.17 M(-2.6%) | $53.76 M(+5.6%) |
| Mar 2022 | - | $14.56 M(+6.4%) | $50.91 M(+7.7%) |
| Dec 2021 | $47.25 M(+5.9%) | $13.68 M(+20.6%) | $47.25 M(+6.3%) |
| Sept 2021 | - | $11.35 M(+0.2%) | $44.47 M(-0.0%) |
| June 2021 | - | $11.32 M(+3.9%) | $44.48 M(+0.3%) |
| Mar 2021 | - | $10.90 M(-0.0%) | $44.35 M(-0.6%) |
| Dec 2020 | $44.64 M(+0.1%) | $10.90 M(-4.0%) | $44.64 M(+3.1%) |
| Sept 2020 | - | $11.36 M(+1.4%) | $43.30 M(+4.6%) |
| June 2020 | - | $11.20 M(+0.1%) | $41.42 M(+4.3%) |
| Mar 2020 | - | $11.18 M(+16.9%) | $39.69 M(-11.0%) |
| Dec 2019 | $44.61 M(+32.2%) | $9.56 M(+1.0%) | $44.61 M(+2.0%) |
| Sept 2019 | - | $9.47 M(+0.0%) | $43.73 M(+2.2%) |
| June 2019 | - | $9.47 M(-41.2%) | $42.81 M(+2.8%) |
| Mar 2019 | - | $16.10 M(+85.4%) | $41.65 M(+23.4%) |
| Dec 2018 | $33.74 M(+20.8%) | $8.69 M(+1.6%) | $33.74 M(+5.2%) |
| Sept 2018 | - | $8.55 M(+2.8%) | $32.08 M(+4.7%) |
| June 2018 | - | $8.31 M(+1.4%) | $30.63 M(+4.1%) |
| Mar 2018 | - | $8.20 M(+16.7%) | $29.42 M(+5.3%) |
| Dec 2017 | $27.93 M(+25.0%) | $7.02 M(-1.1%) | $27.93 M(+4.5%) |
| Sept 2017 | - | $7.10 M(-0.0%) | $26.72 M(+4.4%) |
| June 2017 | - | $7.10 M(+5.9%) | $25.59 M(+4.7%) |
| Mar 2017 | - | $6.71 M(+15.4%) | $24.44 M(+9.4%) |
| Dec 2016 | $22.34 M(+223.8%) | $5.81 M(-2.6%) | $22.34 M(+19.9%) |
| Sept 2016 | - | $5.97 M(+0.2%) | $18.64 M(+26.6%) |
| June 2016 | - | $5.96 M(+29.2%) | $14.72 M(+44.6%) |
| Mar 2016 | - | $4.61 M(+118.3%) | $10.18 M(+47.6%) |
| Dec 2015 | $6.90 M(+77.9%) | $2.11 M(+3.1%) | $6.90 M(+13.7%) |
| Sept 2015 | - | $2.05 M(+44.7%) | $6.07 M(+16.5%) |
| June 2015 | - | $1.42 M(+6.6%) | $5.21 M(+15.7%) |
| Mar 2015 | - | $1.33 M(+3.5%) | $4.50 M(+16.1%) |
| Dec 2014 | $3.88 M(+249.4%) | $1.28 M(+8.0%) | $3.88 M(+27.9%) |
| Sept 2014 | - | $1.19 M(+68.1%) | $3.03 M(+36.1%) |
| June 2014 | - | $706.00 K(+0.4%) | $2.23 M(+35.3%) |
| Mar 2014 | - | $703.00 K(+60.9%) | $1.65 M(+48.3%) |
| Dec 2013 | $1.11 M(+328.7%) | $437.00 K(+14.4%) | $1.11 M(+31.5%) |
| Sept 2013 | - | $382.00 K(+206.6%) | $844.40 K(+73.0%) |
| June 2013 | - | $124.60 K(-25.1%) | $488.10 K(+23.8%) |
| Mar 2013 | - | $166.40 K(-2.9%) | $394.40 K(+52.3%) |
| Dec 2012 | $258.90 K | $171.40 K(+566.9%) | $258.90 K(+120.2%) |
| Sept 2012 | - | $25.70 K(-16.8%) | $117.60 K(-7.8%) |
| June 2012 | - | $30.90 K(0.0%) | $127.60 K(-7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $30.90 K(+2.7%) | $137.20 K(-7.4%) |
| Dec 2011 | $148.20 K(-11.8%) | $30.10 K(-15.7%) | $148.20 K(-5.7%) |
| Sept 2011 | - | $35.70 K(-11.9%) | $157.10 K(-3.3%) |
| June 2011 | - | $40.50 K(-3.3%) | $162.40 K(-1.2%) |
| Mar 2011 | - | $41.90 K(+7.4%) | $164.40 K(-2.1%) |
| Dec 2010 | $168.00 K(+22.4%) | $39.00 K(-4.9%) | $167.90 K(-1.4%) |
| Sept 2010 | - | $41.00 K(-3.5%) | $170.30 K(+4.7%) |
| June 2010 | - | $42.50 K(-6.4%) | $162.60 K(+6.0%) |
| Mar 2010 | - | $45.40 K(+9.7%) | $153.40 K(+11.8%) |
| Dec 2009 | $137.30 K(+218.6%) | $41.40 K(+24.3%) | $137.20 K(+30.5%) |
| Sept 2009 | - | $33.30 K(0.0%) | $105.10 K(+25.7%) |
| June 2009 | - | $33.30 K(+14.0%) | $83.60 K(+33.5%) |
| Mar 2009 | - | $29.20 K(+214.0%) | $62.60 K(+44.9%) |
| Dec 2008 | $43.10 K(-52.0%) | $9300.00(-21.2%) | $43.20 K(-2.3%) |
| Sept 2008 | - | $11.80 K(-4.1%) | $44.20 K(-12.3%) |
| June 2008 | - | $12.30 K(+25.5%) | $50.40 K(-24.4%) |
| Mar 2008 | - | $9800.00(-4.9%) | $66.70 K(-25.7%) |
| Dec 2007 | $89.80 K(-23.8%) | $10.30 K(-42.8%) | $89.80 K(-19.8%) |
| Sept 2007 | - | $18.00 K(-37.1%) | $112.00 K(-10.2%) |
| June 2007 | - | $28.60 K(-13.1%) | $124.70 K(+1.2%) |
| Mar 2007 | - | $32.90 K(+1.2%) | $123.20 K(+4.6%) |
| Dec 2006 | $117.80 K(+16.7%) | $32.50 K(+5.9%) | $117.80 K(+7.3%) |
| Sept 2006 | - | $30.70 K(+13.3%) | $109.80 K(+5.0%) |
| June 2006 | - | $27.10 K(-1.5%) | $104.60 K(+1.1%) |
| Mar 2006 | - | $27.50 K(+12.2%) | $103.50 K(+2.6%) |
| Dec 2005 | $100.90 K(-1.0%) | $24.50 K(-3.9%) | $100.90 K(-2.1%) |
| Sept 2005 | - | $25.50 K(-1.9%) | $103.10 K(-0.7%) |
| June 2005 | - | $26.00 K(+4.4%) | $103.80 K(+0.3%) |
| Mar 2005 | - | $24.90 K(-6.7%) | $103.50 K(+1.6%) |
| Dec 2004 | $101.90 K(+9.7%) | $26.70 K(+1.9%) | $101.90 K(+4.0%) |
| Sept 2004 | - | $26.20 K(+1.9%) | $98.00 K(+3.4%) |
| June 2004 | - | $25.70 K(+10.3%) | $94.80 K(+2.4%) |
| Mar 2004 | - | $23.30 K(+2.2%) | $92.60 K(-0.2%) |
| Dec 2003 | $92.90 K(+0.9%) | $22.80 K(-0.9%) | $92.80 K(-0.7%) |
| Sept 2003 | - | $23.00 K(-2.1%) | $93.50 K(-0.2%) |
| June 2003 | - | $23.50 K(0.0%) | $93.70 K(+0.9%) |
| Mar 2003 | - | $23.50 K(0.0%) | $92.90 K(+0.9%) |
| Dec 2002 | $92.10 K(-16.7%) | $23.50 K(+1.3%) | $92.10 K(+1.0%) |
| Sept 2002 | - | $23.20 K(+2.2%) | $91.20 K(+1.9%) |
| June 2002 | - | $22.70 K(0.0%) | $89.50 K(-10.8%) |
| Mar 2002 | - | $22.70 K(+0.4%) | $100.30 K(-9.3%) |
| Dec 2001 | $110.60 K(-9.9%) | $22.60 K(+5.1%) | $110.60 K(-19.5%) |
| Sept 2001 | - | $21.50 K(-35.8%) | $137.40 K(-2.6%) |
| June 2001 | - | $33.50 K(+1.5%) | $141.10 K(+6.9%) |
| Mar 2001 | - | $33.00 K(-33.2%) | $132.00 K(+7.4%) |
| Dec 2000 | $122.80 K(+34.9%) | $49.40 K(+96.0%) | $122.90 K(+67.2%) |
| Sept 2000 | - | $25.20 K(+3.3%) | $73.50 K(+52.2%) |
| June 2000 | - | $24.40 K(+2.1%) | $48.30 K(+102.1%) |
| Mar 2000 | - | $23.90 K | $23.90 K |
| Dec 1999 | $91.00 K(-34.9%) | - | - |
| Dec 1998 | $139.80 K | - | - |
FAQ
- What is ANI Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual D&A year-on-year change?
- What is ANI Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly D&A year-on-year change?
- What is ANI Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM D&A year-on-year change?
What is ANI Pharmaceuticals annual depreciation & amortization?
The current annual D&A of ANIP is $59.79 M
What is the all time high annual D&A for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual depreciation & amortization is $59.79 M
What is ANI Pharmaceuticals annual D&A year-on-year change?
Over the past year, ANIP annual depreciation & amortization has changed by +$138.00 K (+0.23%)
What is ANI Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of ANIP is $15.75 M
What is the all time high quarterly D&A for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly depreciation & amortization is $16.10 M
What is ANI Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, ANIP quarterly depreciation & amortization has changed by +$541.00 K (+3.56%)
What is ANI Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of ANIP is $60.33 M
What is the all time high TTM D&A for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM depreciation & amortization is $60.33 M
What is ANI Pharmaceuticals TTM D&A year-on-year change?
Over the past year, ANIP TTM depreciation & amortization has changed by +$156.00 K (+0.26%)